GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SCM Lifescience Co Ltd (XKRX:298060) » Definitions » Net Income From Continuing Operations

SCM Lifescience Co (XKRX:298060) Net Income From Continuing Operations : ₩-10,704 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is SCM Lifescience Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. SCM Lifescience Co's net income from continuing operations for the three months ended in Mar. 2025 was ₩-1,540 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-10,704 Mil.

SCM Lifescience Co Net Income From Continuing Operations Historical Data

The historical data trend for SCM Lifescience Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCM Lifescience Co Net Income From Continuing Operations Chart

SCM Lifescience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9,632.80 -22,518.68 -22,930.00 -23,961.42 -12,377.07

SCM Lifescience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,213.65 -2,462.35 -3,072.79 -3,628.29 -1,540.24

SCM Lifescience Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-10,704 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCM Lifescience Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SCM Lifescience Co Ltd (XKRX:298060) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:179530 XKRX:065650 XKRX:322970 XKRX:446440 XKRX:188260 XKRX:327610 XKRX:343090 XKRX:344860 XKRX:199730 XKRX:215380 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
366, 310 Seohae-daero, Jung-gu, Incheon, KOR
Website
http://www.scmlifescience.com
SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, stem cell products in South Korea.

SCM Lifescience Co Headlines

No Headlines